Shouyao Holdings Beijing Co. Ltd.SSE: 688197

Report for Q3 2025

Oct 31, 2025 · Issued by Shouyao Holdings Beijing Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Oct 31, 2025

On 6ix: 6ix.com/news/report-for-q3-2025-610

Report for Q3 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Shouyao Holdings Beijing Co. Ltd. on 6ix

Earlier from Shouyao Holdings Beijing

Announcement on Voluntary Disclosure of Acceptance of the New Drug Application for Marketing of the RET Inhibitor Sotolitinib Tablets (SY-5007)Oct 23, 2025
Announcement on Completing Industrial and Commercial Change Registration and Filing, as well as Obtaining Renewed "Business License"Oct 18, 2025
Announcement on Resolutions of the 1st Extraordinary General Meeting in 2025Sep 16, 2025
Semi-annual Evaluation Report on "Corporate Value and Return Enhancement" Action Plan 2025Aug 28, 2025
Announcement on Using Self-owned Funds to Pay Some Funds for Raised Fund Investment Projects and Replacing Them with an Equal Amount of Raised FundsJun 21, 2025

Later from Shouyao Holdings Beijing

Announcement on Obtaining Government SubsidiesDec 25, 2025
Preliminary Earnings Estimate for 2025Jan 31
Announcement on Voluntary Disclosure of MAT2A Inhibitor SY-9453 Obtaining the Notice of Approval for Drug Clinical TrialsFeb 5
Announcement on Retirement and Resignation of Core Technical PersonnelFeb 13
Announcement on Resignation of DirectorFeb 28

All Shouyao Holdings Beijing news releases

Follow Shouyao Holdings Beijing into a list and get an email when it puts out news.

Follow Shouyao Holdings Beijing